{
    "Trade/Device Name(s)": [
        "PREVU* POC Skin Sterol Test",
        "PREVU* Point of Care (POC) Skin Sterol Test"
    ],
    "Submitter Information": "PreMD, Inc.",
    "510(k) Number": "K062092",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LBS"
    ],
    "Summary Letter Date": "August 18, 2006",
    "Summary Letter Received Date": "August 18, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1475"
    ],
    "Regulation Name(s)": [
        "Lipoprotein Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Skin cholesterol"
    ],
    "Specimen Type(s)": [
        "Skin"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for PREVU* POC Skin Sterol Test for risk assessment of coronary heart disease based on skin cholesterol measurement",
    "Indications for Use Summary": "Used as part of risk assessment for coronary heart disease in persons with history of myocardial infarction or suspected significant multi-vessel coronary artery disease, in conjunction with clinical evaluation and other diagnostic measures",
    "fda_folder": "Clinical Chemistry"
}